
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15345089
[patent_doc_number] => 20200010436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => METHOD FOR PREPARATION OF 3,7-BIS-(DIMETHYLAMINO)-PHENOTHIAZIN-5-IUM CHLORIDE OR BROMIDE
[patent_app_type] => utility
[patent_app_number] => 16/493969
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493969 | Method for preparation of 3,7-bis-(dimethylamino)-phenothiazin-5-ium chloride or bromide | Mar 14, 2018 | Issued |
Array
(
[id] => 16506149
[patent_doc_number] => 20200385405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => INHIBITORS OF MALT1 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/492066
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492066
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492066 | Inhibitors of MALT1 and uses thereof | Mar 7, 2018 | Issued |
Array
(
[id] => 13413135
[patent_doc_number] => 20180258110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => Process for preparing tris[3-(alkoxysilyl)propyl] isocyanurates
[patent_app_type] => utility
[patent_app_number] => 15/915138
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915138
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915138 | Process for preparing tris[3-(alkoxysilyl)propyl] isocyanurates | Mar 7, 2018 | Issued |
Array
(
[id] => 15293493
[patent_doc_number] => 20190389882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => INHIBITORS OF BETA SECRETASE
[patent_app_type] => utility
[patent_app_number] => 16/489910
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489910
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489910 | INHIBITORS OF BETA SECRETASE | Mar 5, 2018 | Abandoned |
Array
(
[id] => 15649431
[patent_doc_number] => 20200087245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => ENAMINE COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/489563
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489563
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489563 | Enamine compound and use thereof | Mar 1, 2018 | Issued |
Array
(
[id] => 14518997
[patent_doc_number] => 10336745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Piperazine-containing two-photon absorbing compounds
[patent_app_type] => utility
[patent_app_number] => 15/910341
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5979
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910341
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/910341 | Piperazine-containing two-photon absorbing compounds | Mar 1, 2018 | Issued |
Array
(
[id] => 16649956
[patent_doc_number] => 10927118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Inhibitors of influenza virus replication and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/489587
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36201
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 892
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489587
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489587 | Inhibitors of influenza virus replication and uses thereof | Feb 28, 2018 | Issued |
Array
(
[id] => 16999380
[patent_doc_number] => 11078170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Cyclic sulfamide compounds and methods of using same
[patent_app_type] => utility
[patent_app_number] => 16/490223
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 98938
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 402
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/490223 | Cyclic sulfamide compounds and methods of using same | Feb 28, 2018 | Issued |
Array
(
[id] => 15260527
[patent_doc_number] => 20190378997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => COMPOUND, LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT
[patent_app_type] => utility
[patent_app_number] => 16/489385
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489385
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489385 | COMPOUND, LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT | Feb 27, 2018 | Abandoned |
Array
(
[id] => 14578423
[patent_doc_number] => 20190216820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => ANTIFUNGAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/307402
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307402
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307402 | Antifungal composition | Feb 26, 2018 | Issued |
Array
(
[id] => 16336624
[patent_doc_number] => 10787571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Oxidation color developable compound and oxidation color development reagent
[patent_app_type] => utility
[patent_app_number] => 16/348235
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 4547
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348235
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348235 | Oxidation color developable compound and oxidation color development reagent | Feb 26, 2018 | Issued |
Array
(
[id] => 15070943
[patent_doc_number] => 10464947
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Tricyclic heterocycles as BET protein inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/906163
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54814
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1342
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15906163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/906163 | Tricyclic heterocycles as BET protein inhibitors | Feb 26, 2018 | Issued |
Array
(
[id] => 15831831
[patent_doc_number] => 20200131197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => CRYSTAL OF CEPHALOSPORIN INTERMEDIATE 7alpha-METHOXY CEPHALOTHIN AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/494276
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494276 | Crystal of cephalosporin intermediate 7a-methoxy cephalothin and method for preparing same | Feb 22, 2018 | Issued |
Array
(
[id] => 16642091
[patent_doc_number] => 10919927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Immune stimulating macrolide
[patent_app_type] => utility
[patent_app_number] => 16/487801
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 15
[patent_no_of_words] => 8131
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487801
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487801 | Immune stimulating macrolide | Feb 21, 2018 | Issued |
Array
(
[id] => 15556621
[patent_doc_number] => 20200062722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Method For The Manufacture of Efavirenz
[patent_app_type] => utility
[patent_app_number] => 16/488975
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488975 | Method for the manufacture of Efavirenz | Feb 14, 2018 | Issued |
Array
(
[id] => 16941039
[patent_doc_number] => 11053260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Tri-cycle compound and applications thereof
[patent_app_type] => utility
[patent_app_number] => 16/488244
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 32355
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488244 | Tri-cycle compound and applications thereof | Feb 8, 2018 | Issued |
Array
(
[id] => 15178055
[patent_doc_number] => 20190359619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SOLID STATE FORMS OF REMIMAZOLAM SALTS
[patent_app_type] => utility
[patent_app_number] => 16/484165
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484165 | Process for the preparation of Remimazolam and solid state forms of Remimazolam salts | Feb 7, 2018 | Issued |
Array
(
[id] => 13427919
[patent_doc_number] => 20180265502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/890648
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890648
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/890648 | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORg and the treatment of disease | Feb 6, 2018 | Issued |
Array
(
[id] => 15320971
[patent_doc_number] => 20200000815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => RORGAMMA MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/481200
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481200
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481200 | Rorgamma modulators and uses thereof | Jan 28, 2018 | Issued |
Array
(
[id] => 16784952
[patent_doc_number] => 10987351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => RORgamma modulators and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/481140
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 17
[patent_no_of_words] => 24400
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 334
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481140 | RORgamma modulators and uses thereof | Jan 28, 2018 | Issued |